José Xavier Do Nascimento Junior

José Xavier Do Nascimento Junior

Auto-generated profile, based on publicly available information

José Xavier Do Nascimento Junior

The MetaboliZSm GrouP, Departamento de Biotecnologia Farmacêutica, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-902, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JJJosé Xavier Do Nascimento Júnior
José Xavier Do Nascimento Júnior
Mauro Sola-PennaMauro Sola-Penna
Mauro Sola-Penna
PZPatricia Zancan
Patricia Zancan

7 January 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
JJJosé Xavier Do Nascimento Júnior
José Xavier Do Nascimento Júnior
JGJúlia da Conceição Gomes
Júlia da Conceição Gomes
RFRicardo Imbroisi Filho
Ricardo Imbroisi Filho
HVHelber de Maia Valença
Helber de Maia Valença
JBJéssica Ristow Branco
Jéssica Ristow Branco
PZPatricia Zancan
Patricia Zancan
Metabolic alterations are related to tumorigenesis and other age-related diseases that are accelerated by “Westernized” diets. In fact, hypercaloric nutrition is associated with an increased incidence of cancers and faster aging. Conversely, lifespan-extending strategies, such as caloric restriction, impose beneficial effects on both processes. Here, we investigated the metabolic consequences of hypercaloric-induced aging on tumor growth in female mice. Our findings indicate that a high-fat high-sucrose diet increases tumor growth mainly due to the boosted oxidation of glucose and fatty acids. Consequently, through an increased expression of lactate, IGFBP3, and PTHLH, tumors modulate liver and white adipose tissue metabolism. In the liver, the induced tumor increases fibrosis and accelerates the senescence process, despite the lower systemic pro-inflammatory state. Importantly, the induced tumor induces the wasting and browning of white adipose tissue, thereby reversing diet-induced insulin resistance. Finally, we suggest that tumor growth alters liver-adipose tissue crosstalk that upregulates Fgf21, induces senescence, and negatively modulates lipids and carbohydrates metabolism even in caloric-restricted-fed mice.

31 October 2025 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
LPLarissa Pereira Paixão
Larissa Pereira Paixão
JJJosé Xavier Do Nascimento Junior
José Xavier Do Nascimento Junior
MSMaria Eduarda Sant'ANa Faria Do Espírito Santo
Maria Eduarda Sant'ANa Faria Do Espírito Santo
RFRicardo Imbroisi Filho
Ricardo Imbroisi Filho
JLJoão Gabriel Bernardo Leandro
João Gabriel Bernardo Leandro
PZPatricia Zancan
Patricia Zancan

2 May 2025 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
ECEmylle Costa-Bartuli
Emylle Costa-Bartuli
LPLarissa Pereira Paixão
Larissa Pereira Paixão
LCLeticia Diniz Crepaldi
Leticia Diniz Crepaldi
RFRhayane da Fonseca
Rhayane da Fonseca
MVMel Vianna
Mel Vianna
Mauro Sola-PennaMauro Sola-Penna
Mauro Sola-Penna

24 June 2026 in Molecular and Cellular Endocrinology
Verified
Journal Article
Open access
MAMatheus Ajackson
Matheus Ajackson
EMElisa Bernardes Monteiro
Elisa Bernardes Monteiro
FMFabiane Ferreira Martins
Fabiane Ferreira Martins
JJJosé Xavier Do Nascimento Junior
José Xavier Do Nascimento Junior
ENEduardo Soares Cavadas Neto
Eduardo Soares Cavadas Neto
JDJulio Daleprane
Julio Daleprane
Metabolic-associated steatotic liver disease (MASLD) is strongly associated with obesity and type 2 diabetes (T2D), emerging as a consequence of sustained disturbances in hepatocellular metabolic signaling, inflammatory regulation, and organelle homeostasis induced by nutritional overload. Sulforaphane (SFN), a dietary bioactive compound, has been associated with metabolic protection, yet its ability to preserve hepatic cellular regulation and ultrastructural integrity during MASLD development remains incompletely defined. In this study, C57BL/6 mice were exposed to a high-fat, high-sucrose diet for 14 weeks to induce MASLD, with concomitant SFN administration (2 mg/kg/day, intraperitoneally, 5 days/week). Hepatic and adipose tissue remodeling, insulin signaling, inflammatory pathways, and subcellular architecture were evaluated using biochemical analyses, histology, gene expression profiling, and transmission electron microscopy. SFN markedly attenuated hepatic steatosis, collagen deposition, and glycogen degeneration, while modulating insulin signaling pathway and shifting hepatic gene expression toward oxidative metabolic pathways. These effects were accompanied by suppression of inflammatory mediators, including Nlrp3, Tnfa, and Il1β. At the ultrastructural level, SFN preserved mitochondrial architecture and endoplasmic reticulum organization, preventing diet-induced organelle stress, lipid overload and energy imbalance. Collectively, these findings demonstrate that SFN protects against diet-induced MASLD by maintaining hepatocellular metabolic and inflammatory regulation and preserving organelle integrity, highlighting the relevance of cellular regulatory mechanisms in the control of hepatic intermediary metabolism.